Alzamend Neuro, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2021 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Alzamend Neuro, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2021 to Q3 2024.
  • Alzamend Neuro, Inc. Entity Common Stock, Shares Outstanding for the quarter ending September 11, 2024 was 3.89M shares, a 96% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 3.89M -93.1M -96% Sep 11, 2024 10-Q 2024-09-11
Q2 2024 841K -96.1M -99.1% Jul 29, 2024 10-K 2024-07-30
Q1 2024 6.87M -89.6M -92.9% Mar 22, 2024 10-Q 2024-03-25
Q4 2023 7.12M -89.3M -92.6% Dec 14, 2023 10-Q 2023-12-15
Q3 2023 96.9M +1.46M +1.53% Sep 12, 2023 10-Q 2023-09-13
Q2 2023 96.9M +1.46M +1.53% Jul 24, 2023 10-K 2023-07-27
Q1 2023 96.4M +6.34M +7.03% Mar 15, 2023 10-Q 2023-03-15
Q4 2022 96.4M +7.58M +8.53% Dec 12, 2022 10-Q 2022-12-12
Q3 2022 95.5M +8.59M +9.89% Sep 13, 2022 10-Q 2022-09-13
Q2 2022 95.5M +10.2M +11.9% Jul 19, 2022 10-K 2022-07-19
Q1 2022 90.1M Mar 15, 2022 10-Q 2022-03-15
Q4 2021 88.9M Dec 13, 2021 10-Q 2021-12-13
Q3 2021 86.9M Sep 13, 2021 10-Q 2021-09-13
Q2 2021 85.3M Jul 20, 2021 10-K 2021-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.